Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




DNA Polymerase Promotes Tuberculosis Drug Resistance

By Biotechdaily staff writers
Posted on 13 May 2003
Researchers have found that possessing multiple copies of the DNA-repair enzyme DNA polymerase (DnaE) gives Mycobacterium tuberculosis (Mtb) a survival advantage by inducing mutations in the population of organisms that resist initial antibiotic treatment and encouraging the rise of drug-resistant mutants.

Tuberculosis kills almost two million people each year, and eight million people develop active TB annually. More...
The medical community is especially concerned by the upsurge in cases of multidrug-resistant tuberculosis.

Investigators at the National Institute of Allergy and Infectious Diseases (NIAID, Bethesda, MD, USA) identified dnaE2 as a gene that was upregulated in vitro by several DNA damaging agents, as well as during infection of mice. Loss of the protein produced by this gene reduced both survival of the bacillus after UV (ultraviolet) irradiation and the virulence of the organism in mice. These findings, published in the April 18, 2003, issue of Cell, explain why UV irradiation of Mtb resulted in increased mutation frequency in the surviving fraction.

"We were surprised to find that MTb uses an enzyme from the major DNA polymerase replication family. In other organisms, including humans, such DNA polymerases are responsible for making perfect copies of DNA before the cell divides. Other DNA polymerases in this family are like straight-A students; they perform almost flawlessly. This is the first error-prone DNA polymerase from this family to be identified,” said contributing author Dr. Clifton Barry, a researcher at NIAID.




Related Links:
National Institute of Allergy and Infectious Diseases (NIAID)

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Aspiration System
VACUSAFE
New
Urine Analyzer
respons® UDS100
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.